254 related articles for article (PubMed ID: 347919)
1. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
Seegers WH
Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
[TBL] [Abstract][Full Text] [Related]
2. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
[TBL] [Abstract][Full Text] [Related]
5. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
7. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
8. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
10. Adverse effect of heparin in thrombin-antithrombin III interaction.
Marciniak E
Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III: a backward glance o'er travel'd roads.
Seegers WH
Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
Kudrjashov BA; Pastorova VE; Lyapina LA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
[TBL] [Abstract][Full Text] [Related]
15. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
Kudriashov BA; Pastorova VE; Liapina LA
Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
[TBL] [Abstract][Full Text] [Related]
16. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
19. The measurement of thrombin in clotting blood by radioimmunoassay.
Shuman MA; Majerus PW
J Clin Invest; 1976 Nov; 58(5):1249-58. PubMed ID: 993343
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
